Insights on the Stroke Management Global Market to 2030 - Featuring Cardinal Health, General Electric and GlaxoSmithKline Among Others - ResearchAndMarkets.com

The "Stroke Management Market by Type and Application: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Tuesday, June 7, 2022
Information
Tags: 
Radiology, Pharmaceutical, Health, Cardiology, Oxygen, Stroke, Korea Disease Control and Prevention Agency, Headache, Fatality, Awareness, Echocardiography, Electrocardiography, Therapy, Cerebral angiography, Center, Brain, Cardiovascular disease, Growth, CT, Diabetes, Face, Incidence, Diagnosis, Tissue plasminogen activator, Walking, Brain damage, Magnetic resonance imaging, Intracranial hemorrhage, Hypoesthesia, MRI, Arm, CAGR, Leg, Coal, Medical imaging, Pharmaceutical industry
Geotags: 
EUROPE, NORTH AMERICA
Summary
Key Points: 
  • The "Stroke Management Market by Type and Application: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering.
  • The global stroke management market was valued at $31,702.20 million in 2020, and is projected to reach $67,771.95 million by 2030, registering a CAGR of 7.8% from 2021 to 2030.
  • Such blood insufficiency causes the brain tissue to die, owing to lack of oxygen for the functioning of the brain, eventually resulting into stroke.
  • Ischemic stroke, hemorrhagic stroke, and transient ischemic stroke are the three main types of strokes.


The "Stroke Management Market by Type and Application: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering.

The global stroke management market was valued at $31,702.20 million in 2020, and is projected to reach $67,771.95 million by 2030, registering a CAGR of 7.8% from 2021 to 2030.

Stroke is caused by lack of blood flow to the brain which can be caused either due to the blockage of the blood supply or a blood vessel within the brain. Such blood insufficiency causes the brain tissue to die, owing to lack of oxygen for the functioning of the brain, eventually resulting into stroke. Stroke is a medical emergency that requires urgent diagnosis and treatment to minimize brain damage.

According to the Centers for Disease Control and Prevention, in 2018, stroke was responsible for one out of every six fatalities caused by cardiovascular disease. Stroke is a leading cause of serious long-term disability. Ischemic stroke, hemorrhagic stroke, and transient ischemic stroke are the three main types of strokes. The main symptoms of stroke are difficulty in speaking, understanding, and walking; headache; numbness or inability to move parts of face, arm, or leg; gradual loss of vision; and others.

Increase in healthcare awareness, rise in incidence of diabetes, surge in number of tobacco users, and growth in geriatric population drive the growth of the market. Moreover, technological advancements for the diagnosis and treatment of stroke also contribute toward the growth of the market. However, high cost of diagnosis and treatment and lack of reimbursement policies are the major barriers for the growth of the market. Ongoing R&D activities in the field of stroke management are expected to offer lucrative opportunities for market expansion during the forecast period.

The stroke management market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into diagnostics and therapeutics. The diagnostics segment is classified into computed tomography scan (CT scan), magnetic resonance imaging (MRI), carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, and others.

The therapeutics segment is classified into tissue plasminogen activator, anticoagulant, antiplatelet, and antihypertensive. By application, it is segmented into ischemic stroke and haemorrhagic stroke. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits

  • This report provides a detailed quantitative analysis of the current market trends and future estimations from 2020 to 2030, which assists to identify the prevailing market opportunities
  • An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans
  • A comprehensive analysis of the factors that drive and restrain the growth of the stroke management market is provided
  • An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves
  • Key market players and their strategies have been analyzed to understand the competitive outlook of the market

Key Market Segments

By Type

  • Diagnostics
  • Computed Tomography Scan (CT scan)
  • Magnetic Resonance Imaging (MRI)
  • Carotid Ultrasound
  • Cerebral Angiography
  • Electrocardiography
  • Echocardiography
  • Others
  • Therapeutics
  • Tissue Plasminogen Activator
  • Anticoagulant
  • Antiplatelet
  • Antihypertensive

By Application

  • Ischemic Stroke
  • Haemorrhagic Stroke

By Region

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players

  • Abbott Laboratories
  • B Braun Melsungen AG
  • Boston Scientific Corporation
  • Bristol-Myers Squibb Company
  • Cardinal Health Inc
  • General Electric Company
  • GlaxoSmithKline Plc
  • Medtronic Plc
  • Merck & Co, Inc
  • Siemens AG

For more information about this report visit https://www.researchandmarkets.com/r/erd70o

Copyright: 
Copyright Business Wire 2022